No Data
No Data
MBX Biosciences to Participate in March Investor Conferences
Earnings Scheduled For February 13, 2025
Smaller Biotechs See New Mechanisms of Actions as Future of Obesity Treatments
Stifel Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $40
Stifel Nicolaus Reaffirms Their Buy Rating on MBX Biosciences, Inc. (MBX)
MBX Biosciences Director Makes Bold Stock Move
Unlock the Full List